1. Home
  2. BA vs SNY Comparison

BA vs SNY Comparison

Compare BA & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BA
  • SNY
  • Stock Information
  • Founded
  • BA 1916
  • SNY 1994
  • Country
  • BA United States
  • SNY France
  • Employees
  • BA N/A
  • SNY N/A
  • Industry
  • BA Aerospace
  • SNY Biotechnology: Pharmaceutical Preparations
  • Sector
  • BA Industrials
  • SNY Health Care
  • Exchange
  • BA Nasdaq
  • SNY Nasdaq
  • Market Cap
  • BA 126.9B
  • SNY 120.2B
  • IPO Year
  • BA N/A
  • SNY N/A
  • Fundamental
  • Price
  • BA $177.49
  • SNY $47.71
  • Analyst Decision
  • BA Buy
  • SNY Buy
  • Analyst Count
  • BA 22
  • SNY 2
  • Target Price
  • BA $195.79
  • SNY $57.50
  • AVG Volume (30 Days)
  • BA 11.5M
  • SNY 2.7M
  • Earning Date
  • BA 01-29-2025
  • SNY 01-30-2025
  • Dividend Yield
  • BA N/A
  • SNY 4.27%
  • EPS Growth
  • BA N/A
  • SNY N/A
  • EPS
  • BA N/A
  • SNY 4.00
  • Revenue
  • BA $73,293,000,000.00
  • SNY $54,031,898,261.00
  • Revenue This Year
  • BA N/A
  • SNY $3.18
  • Revenue Next Year
  • BA $25.35
  • SNY $6.67
  • P/E Ratio
  • BA N/A
  • SNY $23.72
  • Revenue Growth
  • BA N/A
  • SNY 6.01
  • 52 Week Low
  • BA $137.03
  • SNY $45.22
  • 52 Week High
  • BA $264.66
  • SNY $58.97
  • Technical
  • Relative Strength Index (RSI)
  • BA 74.86
  • SNY 45.07
  • Support Level
  • BA $171.00
  • SNY $47.01
  • Resistance Level
  • BA $169.30
  • SNY $49.73
  • Average True Range (ATR)
  • BA 5.54
  • SNY 0.73
  • MACD
  • BA 1.86
  • SNY 0.16
  • Stochastic Oscillator
  • BA 84.23
  • SNY 48.60

About BA Boeing Company (The)

Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and Global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with Lockheed, Northrop, and several other firms to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Share on Social Networks: